<VariationArchive RecordType="classified" VariationID="1526115" VariationName="NM_018668.5(VPS33B):c.1509dup (p.Lys504fs)" VariationType="Duplication" Accession="VCV001526115" Version="2" NumberOfSubmissions="3" NumberOfSubmitters="2" DateLastUpdated="2023-12-25" DateCreated="2022-04-02" MostRecentSubmission="2022-08-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1517519" VariationID="1526115">
      <GeneList>
        <Gene Symbol="VPS33B" FullName="VPS33B late endosome and lysosome associated" GeneID="26276" HGNC_ID="HGNC:12712" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q26.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="90998416" stop="91022621" display_start="90998416" display_stop="91022621" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="91541773" stop="91565832" display_start="91541773" display_stop="91565832" Strand="-" />
          </Location>
          <OMIM>608552</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_018668.5(VPS33B):c.1509dup (p.Lys504fs)</Name>
      <CanonicalSPDI>NC_000015.10:91000561:C:CC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>15q26.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="91000561" stop="91000562" display_start="91000561" display_stop="91000562" variantLength="1" positionVCF="91000561" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="91543791" stop="91543792" display_start="91543791" display_stop="91543792" variantLength="1" positionVCF="91543791" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
      </Location>
      <ProteinChange>K413fs</ProteinChange>
      <ProteinChange>K477fs</ProteinChange>
      <ProteinChange>K504fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_884" sequenceAccession="LRG_884">
            <Expression>LRG_884:g.27042dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.91000562dup" Assembly="GRCh38">
            <Expression>NC_000015.10:g.91000562dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.91543792dup" Assembly="GRCh37">
            <Expression>NC_000015.9:g.91543792dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012162.1" sequenceAccession="NG_012162" sequenceVersion="1" change="g.27042dup">
            <Expression>NG_012162.1:g.27042dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001289148.1" sequenceAccession="NM_001289148" sequenceVersion="1" change="c.1428dup">
            <Expression>NM_001289148.1:c.1428dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001276077.1" sequenceAccession="NP_001276077" sequenceVersion="1" change="p.Lys477fs">
            <Expression>NP_001276077.1:p.Lys477fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001289149.1" sequenceAccession="NM_001289149" sequenceVersion="1" change="c.1236dup">
            <Expression>NM_001289149.1:c.1236dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001276078.1" sequenceAccession="NP_001276078" sequenceVersion="1" change="p.Lys413fs">
            <Expression>NP_001276078.1:p.Lys413fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018668.5" sequenceAccession="NM_018668" sequenceVersion="5" change="c.1509dup" MANESelect="true">
            <Expression>NM_018668.5:c.1509dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_061138.3" sequenceAccession="NP_061138" sequenceVersion="3" change="p.Lys504fs">
            <Expression>NP_061138.3:p.Lys504fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="608552.0012" DB="OMIM" />
        <XRef Type="rs" ID="1209349503" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_018668.5(VPS33B):c.1509dup (p.Lys504fs) AND Arthrogryposis, renal dysfunction, and cholestasis 1" Accession="RCV002052135" Version="2">
        <ClassifiedConditionList TraitSetID="564">
          <ClassifiedCondition DB="MedGen" ID="C1859722">Arthrogryposis, renal dysfunction, and cholestasis 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-22" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_018668.5(VPS33B):c.1509dup (p.Lys504fs) AND Cholestasis, progressive familial intrahepatic, 12" Accession="RCV002276993" Version="1">
        <ClassifiedConditionList TraitSetID="79358">
          <ClassifiedCondition DB="MedGen" ID="C5774311">Cholestasis, progressive familial intrahepatic, 12</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-08-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-22" NumberOfSubmissions="3" NumberOfSubmitters="2" DateCreated="2022-04-02" MostRecentSubmission="2022-08-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18853461</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31479177</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="564" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="451" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Arthrogryposis, renal dysfunction, and cholestasis 1</ElementValue>
                <XRef ID="MONDO:0008822" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ARCS1</ElementValue>
                <XRef Type="MIM" ID="208085" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15139" />
                <XRef ID="15139" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="2697" DB="Orphanet" />
              <XRef ID="C1859722" DB="MedGen" />
              <XRef ID="MONDO:0008822" DB="MONDO" />
              <XRef Type="MIM" ID="208085" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="79358" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="65740" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cholestasis, progressive familial intrahepatic, 12</ElementValue>
                <XRef ID="MONDO:0031040" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHOLESTASIS, ISOLATED LOW-GGT</ElementValue>
                <XRef Type="MIM" ID="620010" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PFIC12</ElementValue>
                <XRef Type="MIM" ID="620010" DB="OMIM" />
              </Symbol>
              <XRef ID="C5774311" DB="MedGen" />
              <XRef ID="MONDO:0031040" DB="MONDO" />
              <XRef Type="MIM" ID="620010" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4538391" SubmissionDate="2022-03-25" DateLastUpdated="2022-04-02" DateCreated="2022-04-02">
        <ClinVarSubmissionID localKey="15-91543791-T-TC" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002318619" DateUpdated="2022-04-02" DateCreated="2022-04-02" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18853461</ID>
          </Citation>
          <Comment>Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. It is not observed in the gnomAD v2.1.1 dataset. This variant has been reported to be associated with VPS33B related disorder (PMID:18853461). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001396" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001838" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VPS33B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018668.5:c.1509dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="208085" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11208158</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5013491" SubmissionDate="2022-08-18" DateLastUpdated="2022-08-29" DateCreated="2022-08-29">
        <ClinVarSubmissionID localKey="608552.0012_ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1" title="VPS33B, 1-BP DUP, 109G_ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1" />
        <ClinVarAccession Accession="SCV002564412" DateUpdated="2022-08-29" DateCreated="2022-08-29" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-18">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Progressive Familial Intrahepatic Cholestasis 12</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 1-bp duplication (c.109dupG, NM_018668.4) in the VPS33B gene, causing a frameshift predicted to result in a premature termination codon (Lys504GlufsTer), that was found in compound heterozygous state in a Chinese brother (P2) and sister (P3) with isolated cholestasis (PFIC12; 610010) by Qiu et al. (2019), see 608552.0011.</Attribute>
              <Citation>
                <ID Source="PubMed">31479177</ID>
              </Citation>
              <XRef DB="OMIM" ID="610010" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Arthrogryposis, Renal Dysfunction, and Cholestasis 1</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a Chinese female infant (P4) who died at the age of 6 months with arthrogryposis, renal dysfunction, and cholestasis-1 (ARCS1; 208085), Qiu et al. (2019) identified compound heterozygosity for the c.109dupG mutation and a splice site mutation (c.403+2T-A; 608552.0013).</Attribute>
              <Citation>
                <ID Source="PubMed">31479177</ID>
              </Citation>
              <XRef DB="OMIM" ID="208085" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VPS33B" />
          </GeneList>
          <Name>VPS33B, 1-BP DUP, 109G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 109G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608552.0012" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5013497" SubmissionDate="2022-08-18" DateLastUpdated="2022-08-29" DateCreated="2022-08-29">
        <ClinVarSubmissionID localKey="608552.0012_CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 12" title="VPS33B, 1-BP DUP, 109G_CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 12" />
        <ClinVarAccession Accession="SCV002564418" DateUpdated="2022-08-29" DateCreated="2022-08-29" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-18">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Progressive Familial Intrahepatic Cholestasis 12</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 1-bp duplication (c.109dupG, NM_018668.4) in the VPS33B gene, causing a frameshift predicted to result in a premature termination codon (Lys504GlufsTer), that was found in compound heterozygous state in a Chinese brother (P2) and sister (P3) with isolated cholestasis (PFIC12; 610010) by Qiu et al. (2019), see 608552.0011.</Attribute>
              <Citation>
                <ID Source="PubMed">31479177</ID>
              </Citation>
              <XRef DB="OMIM" ID="610010" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Arthrogryposis, Renal Dysfunction, and Cholestasis 1</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a Chinese female infant (P4) who died at the age of 6 months with arthrogryposis, renal dysfunction, and cholestasis-1 (ARCS1; 208085), Qiu et al. (2019) identified compound heterozygosity for the c.109dupG mutation and a splice site mutation (c.403+2T-A; 608552.0013).</Attribute>
              <Citation>
                <ID Source="PubMed">31479177</ID>
              </Citation>
              <XRef DB="OMIM" ID="208085" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VPS33B" />
          </GeneList>
          <Name>VPS33B, 1-BP DUP, 109G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 109G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608552.0012" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 12</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4538391" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001838" MappingRef="HP">
        <MedGen CUI="C0240912" Name="Congenital vertical talus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4538391" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001396" MappingRef="HP">
        <MedGen CUI="C0008370" Name="Cholestasis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5013497" TraitType="Disease" MappingType="Name" MappingValue="CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 12" MappingRef="Preferred">
        <MedGen CUI="C5774311" Name="Cholestasis, progressive familial intrahepatic, 12" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4538391" TraitType="Disease" MappingType="XRef" MappingValue="208085" MappingRef="OMIM">
        <MedGen CUI="C1859722" Name="Arthrogryposis, renal dysfunction, and cholestasis 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5013491" TraitType="Disease" MappingType="Name" MappingValue="ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1" MappingRef="Alternate">
        <MedGen CUI="C1859722" Name="Arthrogryposis, renal dysfunction, and cholestasis 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

